EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Lisata Therapeutics, Inc. (LSTA) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-4.25M |
|
-- |
|
-- |
|
$4.41M |
|
$-4.41M |
|
$0.17M |
|
$-4.25M |
|
$-4.25M |
|
$-4.25M |
|
$-4.25M |
|
$-4.25M |
|
$-4.25M |
|
$-4.41M |
|
$-4.38M |
|
8.74M |
|
8.74M |
|
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$21.57M |
|
$0.02M |
|
$0.18M |
|
$21.76M |
|
$4.57M |
|
-- |
|
$0.07M |
|
$4.64M |
|
$17.12M |
|
$16.98M |
|
$17.12M |
|
8.76M |
|
| Cash Flow Statement Financials | |
$-12.70M |
|
$15.09M |
|
$0.39M |
|
$16.21M |
|
$19.00M |
|
$2.79M |
|
$1.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-12.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.82% |
|
-25.02% |
|
-19.53% |
|
-24.82% |
|
$1.96 |
|
$-1.46 |
|
$-1.45 |
|